Project Details
Abstract
The validation of a unique gene signature for triple negative breast cancer (TNBC) prognosis and predicting benefit for immunotherapy
Submitting Institute Name
Hamad Bin Khalifa University (HBKU)
| Sponsor's Award Number | IGP5-2022-003 |
|---|---|
| Proposal ID | QBRI-CORE-000006 |
| Status | Finished |
| Effective start/end date | 1/01/23 → 31/12/25 |
Collaborative partners
- Hamad Bin Khalifa University (lead)
- Hamad Medical Corporation
Primary Theme
- Precision Health
Primary Subtheme
- PH - Diagnosis Treatment
Secondary Theme
- None
Secondary Subtheme
- None
Keywords
- Breast cancer, Age Standardized Rate (ASR), Biomarker, Precision oncology.
- None
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.